Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Slack

Showing results (391-400 of 472) with videos related to

Pageof 48
Sort By:
Oncogene|December 8, 2009
Regression of murine lung tumors by the let-7 microRNAP Trang, P P Medina, J F Wiggins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responsesJ G Giri, J Wells, S K Dower, et al.
Clinical Drug Investigation|October 2, 2024
Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic ImpairmentVassilios Aslanis, Michael Gray, Robert J Slack, et al.
Oncogene|June 10, 2014
Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancerX Chen, T Paranjape, C Stahlhut, et al.
Journal of Nuclear Medicine Technology|February 14, 2018
A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of <sup>18</sup>F-FB-A20FMDV2 for Imaging the Integrin α<sub>v</sub>β<sub>6</sub>Nicholas Keat, Julia Kenny, Keguan Chen, et al.
British Journal of Pharmacology|October 26, 2011
Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptorsR J Slack, L J Russell, D A Hall, et al.
Pharmacology Research & Perspectives|December 16, 2014
Antagonism of human CC-chemokine receptor 4 can be achieved through three distinct binding sites on the receptorRobert J Slack, Linda J Russell, Nick P Barton, et al.
International Journal of Molecular Sciences|June 27, 2024
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon ResonanceHenry Kim, Louis Kretz, Céline Ronin, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2023
Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonanceHenry Kim, Nathalie Weidner, Céline Ronin, et al.
Cancer Research|August 19, 2007
The let-7 microRNA represses cell proliferation pathways in human cellsCharles D Johnson, Aurora Esquela-Kerscher, Giovanni Stefani, et al.
Pageof 48

Showing results (391-400 of 472) with videos related to

Sort By:
Pageof 48
Oncogene|December 8, 2009
Regression of murine lung tumors by the let-7 microRNAP Trang, P P Medina, J F Wiggins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responsesJ G Giri, J Wells, S K Dower, et al.
Clinical Drug Investigation|October 2, 2024
Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic ImpairmentVassilios Aslanis, Michael Gray, Robert J Slack, et al.
Oncogene|June 10, 2014
Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancerX Chen, T Paranjape, C Stahlhut, et al.
Journal of Nuclear Medicine Technology|February 14, 2018
A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of <sup>18</sup>F-FB-A20FMDV2 for Imaging the Integrin α<sub>v</sub>β<sub>6</sub>Nicholas Keat, Julia Kenny, Keguan Chen, et al.
British Journal of Pharmacology|October 26, 2011
Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptorsR J Slack, L J Russell, D A Hall, et al.
Pharmacology Research & Perspectives|December 16, 2014
Antagonism of human CC-chemokine receptor 4 can be achieved through three distinct binding sites on the receptorRobert J Slack, Linda J Russell, Nick P Barton, et al.
International Journal of Molecular Sciences|June 27, 2024
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon ResonanceHenry Kim, Louis Kretz, Céline Ronin, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2023
Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonanceHenry Kim, Nathalie Weidner, Céline Ronin, et al.
Cancer Research|August 19, 2007
The let-7 microRNA represses cell proliferation pathways in human cellsCharles D Johnson, Aurora Esquela-Kerscher, Giovanni Stefani, et al.
Pageof 48